What's gonna happen when someone on contrave commits suicide? Its on the label. Death drug. Amazing EU approved it and not the much safer Belviq.
Sentiment: Strong Buy
For those of us in for the long term with some cash to use, the falling share price is a dream come true. Anyone with half a brain that read the results recently on NASH, Belphen, etc. know what's in store for this company. Its nice to be able to pilfer some shares from the hedgies who are selling to each other to drop the price. See u at much higher prices next year.
Sentiment: Strong Buy
Duh. Look at the C refills. People are trying it as the lowest cost option but not refilling. C RX's will stabilize and then start dropping. Then what are you going to fabricate?
When you're dead from taking C or Q of course you won't progress to diabetes. I'd rather take B and live.
"High patient interest". Once this is approved it should take some nice market share. Also like the recent insider purchases on the open market in the 100's of thousands of shares. PPS will start moving after the first of the year in anticipation of trial completion and results.
Yes, we'll know they are not good market timers. Lief is gonna be kicking himself for selling when the news hits.
Is it legal for ARNA to "encourage" off label use? Could the FDA allow it given the great PII results?
You must not get migranes. You want to put a bullet in your head when they are bad. To get relief in 15 minutes I would do just about anything even take a shot. Nose inhaler is a no brainer. This will sell like hotcakes. Just wait
Yes, but sometimes the buyer and seller are the same person. Its called manipulation and will continue until the SEC gets off their behinds and does something about it.
You have us mixed up with Contrave. Taking Contrave may lead to suicide. Taking Belviq sheds weight, reduces insiin intake, helps you stop smoking, and improves cardiovascular health. Wonder drug of the future.
Guess the trial is going good.
Many companies trade at multiples of that with half the pipeline. Upfront $ from partner could eclipse the market cap. Just doesn't add up.